FDA Inspection 796132 — Sher Fertility Solutions New York

Sher Fertility Solutions New York — FEI 3005202232

The FDA completed an inspection of Sher Fertility Solutions New York on August 31, 2012 in New York, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 4 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 31, 2012
Fiscal Year
2012
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
New York, NY (United States)

Citations

IDCFRDescription
1221321 CFR 1271.47(a)Testing, screening, donor eligibility procedures
1224721 CFR 1271.55(d)(2)Accurate, indelible, legible
1227221 CFR 1271.65(b)(2)Labeled re: biohazard, risks, test results
1228621 CFR 1271.80(b)Specimen collections not timely